This webinar will present modelling hepatitis C elimination among people who inject drugs.
This seminar will present modelled estimates of the health and economic benefits of achieving hepatitis C elimination in Australia. In order to achieve elimination and realize these benefits, uptake of testing and treatment must be high among people who inject drugs. The seminar will also look at a recent modelling study on the impact and cost-effectiveness of incentives to facilitate testing and treatment uptake among people who inject drugs.
About the speaker
Dr Nick Scott, BSc (hons), PhD (Mathematics) is the Head of Modelling & Biostatistics at the Burnet Institute, an Adjunct Senior Research Fellow at Monash University, and an NHMRC Emerging Leader Fellow. He leads a team of modellers who work across a number of infectious diseases and public health problems, particularly those impacting vulnerable populations.